Abstract
Background: Providing unrestricted access to directly acting antiviral drugs (DAAs), Australia is committed to eradicating HCV. Innovations in models of care (MOC) and decentralization of HCV care to avoid limitations of specialist tertiary care models are two of the strategies used to augment treatment capacity.
Original language | English |
---|---|
Article number | 976 |
Pages (from-to) | 569A |
Number of pages | 1 |
Journal | Hepatology |
Volume | 68 |
Issue number | S1 |
DOIs | |
Publication status | Published - Oct 2018 |
Event | Liver Meeting 2018: Annual Meeting of the American Association for the Study of Liver Diseases - San Francisco, United States Duration: 9 Nov 2018 → 13 Nov 2018 https://liverlearning.aasld.org/the-liver-meeting-2018-content |
Keywords
- Models of care
- HCV treatment
- South Australia
- Directly acting antiviral drugs